Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study.

Intravenous infusion of up to 20 mg of BPC-157 in 2 healthy adults showed no adverse effects and was well-tolerated. The results of this pilot study showed the safety of BPC-157 in humans. Future studies are also needed to confirm the safety of intravenous BPC-157 in humans.

Authors

Edwin Ho Ming Lee (ORCID: https://orcid.org/0000-0002-8909-0676)
Kimberly Burgess

Publication Details

Journal: PubMed
Published: 2025-09-01
Citations: 3
Primary Topic: Pharmaceutical studies and practices
Type: article
Field-Weighted Citation Impact: 10.48

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study.

Edwin Ho Ming Lee, Kimberly Burgess

Sep 1, 2025

3 citations

PubMed

Pharmaceutical studies and practices

10.48

article

Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study.

Edwin Ho Ming Lee, Kimberly Burgess

September 1, 2025article en

3 citations

Abstract

PubMedVol. 31(5)

Openalex Percentile: Top 3%

Pharmaceutical studies and practices

10.48

OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. — Edwin Ho Ming Lee, Kimberly Burgess · PubMed (2025) | TGRS Research Map | TGRS